RYO TAMURA

Last Updated :2023/01/06

Affiliations, Positions
Hiroshima University Hospital(Blood Purification), Assistant Professor
E-mail
ryothiroshima-u.ac.jp
Self-introduction
I'm from Hiroshima prefecture. My specialty is nephrology.

Basic Information

Major Professional Backgrounds

  • 2013/04/01, 2015/03/31, JA Hiroshima general, Hospital, Clinical Fellow
  • 2015/04/01, 2016/03/31, Hiroshima University, Hospital, Clinical Fellow
  • 2019/04/01, 2019/04/30, Hiroshima University, Hospital, Clinical Fellow
  • 2019/05/01, Hiroshima University, Hospital, Assistant Professor

Educational Backgrounds

  • Hiroshima University, Graduate School of Biomedical & Health Sciences , Japan, 2016/04, 2019/03
  • Hiroshima University, Faculty of Medicine, Japan, 2005/04, 2011/03

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Kidney internal medicine

Affiliated Academic Societies

  • The Japanese Society of Internal Medicine
  • The Japanese Society of Nephrology
  • The Japanese Society for Dialysis Therapy

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2022, Undergraduate Education, Intensive, Introduction to clinical clerkship
  3. 2022, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2022, Undergraduate Education, Intensive, Practice of Medicine II

Research Activities

Academic Papers

  1. ★, Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, PLoS One, 13(5)
  2. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 24(5), 435-443, 202005
  3. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210323

Invited Lecture, Oral Presentation, Poster Presentation

  1. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis, Ryo Tamura, Ayumu Nakashima, Kohei Nagasaki, Toshinori Ueno, Naoki Ishiuchi, Toshiki Doi, Shigehiro Doi, Yukio Doi, Takao Masaki, The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis, 2019, Without Invitation, English, Nagoya
  2. Inhibition of H3K4 methyltransferase SET7/9 Ameliorates Peritoneal Fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, ISN Frontier Meetings 2018, 2018, Without Invitation, English, Tokyo
  3. Inhibition of H3K4 methyltransferase SET7/9 Ameliorates Peritoneal Fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, American Society of Nephrology Kidney Week 2017, 2017, Without Invitation, English, New Orleans

Awards

  1. 2018, ISN Frontier Meetings 2018, Top 10% Ranked Poster Award
  2. 2019, The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis, Best Abstract Award